Metraipolis › archive › dc_fa4d21d1d5fd
Case report: Unilateral optic atrophy and intracranial hypertension in anti-NF155 nodopathy: a case managed with sequential efgartigimod and rituximab — Europe PMC PMID:42004971
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42004971
- DOI
- 10.3389/fimmu.2026.1770128
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T10:50:27.010Z
- SHA-256 of the archived text
7da9350125263708580d0db48cbe8aaf567c0b46574e3921343c802273512c7d- Stable URL of this page
https://metraipolis.com/documento/dc_fa4d21d1d5fd
How to cite
Case report: Unilateral optic atrophy and intracranial hypertension in anti-NF155 nodopathy: a case managed with sequential efgartigimod and rituximab — Europe PMC PMID:42004971 — Europe PMC (en), https://europepmc.org/article/MED/42004971 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fa4d21d1d5fd (Metraipolis archive dc_fa4d21d1d5fd, sha256 7da9350125263708580d0db48cbe8aaf567c0b46574e3921343c802273512c7d)
BibTeX
@misc{dcfa4d21d1d5fd,
title = {Case report: Unilateral optic atrophy and intracranial hypertension in anti-NF155 nodopathy: a case managed with sequential efgartigimod and rituximab — Europe PMC PMID:42004971},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42004971},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fa4d21d1d5fd; sha256 7da9350125263708580d0db48cbe8aaf567c0b46574e3921343c802273512c7d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42004971. Agents can read the archived copy with the MCP tool read_document.